TABLE 1

Patient Characteristics

CharacteristicData
Age (y)72 (56–81)
Time since diagnosis of PCa (y)7 (0.6–21)
PSA at diagnosis (ng/mL)36 (2.5–308)
Gleason score at diagnosis*
 <87 (44%)
 ≥88 (50%)
T stage at diagnosis*
 T11 (6%)
 T211 (66%)
 T33 (18%)
M status at diagnosis†
 M015 (94%)
 M11 (6%)
Primary treatment‡
 Prostatectomy ± lymphadenectomy7 (49%)
 Local radiotherapy6 (42%)
 Systemic treatment1 (7%)
Salvage treatment
 None9 (56%)
 Radiotherapy3 (19%)
 Systemic treatment4 (25%)
Indication for scan
 Primary staging2 (12%)
 Biochemical recurrence7 (42%)
 Metastatic restaging7 (42%)
PSA at time of PSMA (ng/mL)6.2 (0.2–53.7)

  • ↵* Data missing for 1 patient.

  • ↵† M1 was defined as metastatic disease (distant metastases).

  • ↵‡ Data missing for 2 patients.

  • Qualitative data are number and percentage (total n = 16); continuous data are median and range.